K. Erlenbach-Wuensch

A partial epithelial‐mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restriction

A. Naccarati, R. Schneider-Stock, Philipp Kunze, 2024, The Journal of pathology.

A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer

A. Hartmann, R. Schneider-Stock, A. Berninger, 2021, Cancers.

EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells

A. Hartmann, Sushmita Paul, R. Schneider-Stock, 2020, Cell Death & Disease.

DNA demethylation and tri-methylation of H3K4 at the TACSTD2 promoter are complementary players for TROP2 regulation in colorectal cancer cells

H. Rani, K. Erlenbach-Wuensch, A. Gehring, 2024, Scientific reports.

ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2

Sushmita Paul, R. Schneider-Stock, J. Tureckova, 2022, Cellular and Molecular Life Sciences.

ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway

R. Schneider-Stock, Han Yang, C. Geppert, 2023, BMC Cancer.

Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells

A. Hartmann, R. Schneider-Stock, A. Agaimy, 2019, Cell Death & Disease.

Post-Transcriptional Regulation of Rab7a in Lysosomal Positioning and Drug Resistance in Nutrient-Limited Cancer Cells.

N. Liv, K. Huebner, Ilir Sheraj, 2024, Traffic.